Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease

BACKGROUND: Sorafenib is the recommended treatment for advanced hepatocellular carcinoma (HCC), but transarterial chemoembolization (TACE) is performed in individual cases with limited extrahepatic spread. The aim of this study was to compare the outcome of patients with HCC and extrahepatic disease...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:United European Gastroenterol J
Autori principali: Kirstein, Martha M, Voigtländer, Torsten, Schweitzer, Nora, Hinrichs, Jan B, Marquardt, Jens, Wörns, Marcus-Alexander, Kloeckner, Roman, Fründt, Thorben W, Ittrich, Harald, Wacker, Frank, Rodt, Thomas, Manns, Michael P, Wege, Henning, Weinmann, Arndt, Vogel, Arndt
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833223/
https://ncbi.nlm.nih.gov/pubmed/29511553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617716597
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi